HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 203 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $335,630 | +3.0% | 10,242 | +10.6% | 0.00% | 0.0% |
| Q2 2023 | $325,859 | +45.2% | 9,260 | +34.7% | 0.00% | +50.0% |
| Q1 2023 | $224,469 | -39.0% | 6,875 | +3.0% | 0.00% | -50.0% |
| Q4 2022 | $367,903 | +29.5% | 6,677 | +4.0% | 0.00% | +33.3% |
| Q3 2022 | $284,000 | -8.1% | 6,419 | +1.3% | 0.00% | 0.0% |
| Q2 2022 | $309,000 | +33.8% | 6,338 | +33.7% | 0.00% | +50.0% |
| Q1 2022 | $231,000 | – | 4,742 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |